Showing results (61-70 of 97) with videos related to
Sort By:
Pageof 10
Annals of the Rheumatic Diseases|April 4, 2008
The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosusL C Doward, S P McKenna, D Whalley, et al.Clinical and Vaccine Immunology : CVI|February 10, 2006
Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassayP A C Maple, J Gray, J Breuer, et al.Vaccines|September 3, 2020
An Absence of Epstein-Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm VaccinationPeter A C Maple, Bruno Gran, Radu Tanasescu, et al.Rheumatology (Oxford, England)|May 5, 2007
Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritisC A E Walsh, P Minnock, C Slattery, et al.British Journal of Rheumatology|October 1, 1994
A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritisD J Veale, H I Torley, I M Richards, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 1, 2008
Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assayP A C Maple, P Rathod, E Smit, et al.Vaccine|March 9, 2004
Sero-epidemiology of Bordetella pertussis in England and WalesA Nardone, R G Pebody, P A C Maple, et al.Circulation|April 15, 1997
The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplastyJ J Belch, J W Shaw, G Kirk, et al.Annals of the Rheumatic Diseases|March 17, 2004
Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countriesA D Woolf, H Zeidler, U Haglund, et al.Scandinavian Journal of Rheumatology|April 24, 2018
Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients?V Torrente-Segarra, S A Bergstra, K Solomon-Escoto, et al.Pageof 10